Hema Pharmaceuticals is engaged in manufacturing and supplying the Febuxostat in the market. This medicine belongs to the class of medications known as Xanthine Oxidase Inhibitors. It works by reducing the amount of uric acid made in the body of people suffering from gout. Gout is a kind of arthritis in which uric acid progress in the joints and results in sudden attacks of inflammation, swelling, pain, and heat, in one or more joints. It is used for the treatment of chronic gout and hyperuricemia. It non competitively blocks the molybdenum pterin center.

Features of Febuxostat:

• Used in its chronic management
• Associated with elevated serum uric acid levels
• Eliminated by both renal and hepatic pathway
• Reduce the amount of uric acid